Loading
This page follows insider dealings at פרפל ביוטק as filed with TASE (ISA). The last twelve months, up to 18 October 2026, brought 3 filings signed by 3 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Compared with its exchange (530 companies, median 14 filings), a count of 3 filings is below the norm.
There has been no open-market purchase by an insider of פרפל ביוטק for at least a year.
These figures are compiled from regulatory filings published by TASE (ISA). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
3 of 3 declarations
Purple Biotech is a company operating on the XTAE market, specializing in the biotechnology sector.